DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

Bank

Position in ABBV — AbbVie Inc.

CIK 1694217 FRANKFURT AM MAIN, 2M

Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$726,121,560

+$488,777,989 QoQ

Shares Held

2,885,557

+164.4% QoQ

Ownership

0.163%

of shares outstanding

% of Portfolio

0.58%

of 13F equity value

Holder Rank

#63

of 4,153 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 49% Shared 0% None 51%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $6,628,918,596 across 11 Drug Manufacturers - General names. ABBV ranks #4 (11.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	11,720,479	$2,222,437,225
2	LLY	ELI LILLY & Co	1,338,915	$1,605,934,947
3	JNJ	Johnson & Johnson	5,378,305	$1,365,928,118
4	ABBV	AbbVie Inc. This page	2,885,557	$726,121,560
5	GILD	Gilead Sciences, Inc.	2,628,110	$332,035,416
6	MRK	Merck & Co., Inc.	1,506,793	$193,622,900
7	AMGN	Amgen Inc	278,356	$100,798,272
8	BMY	Bristol Myers Squibb Co	895,583	$51,603,492

All Filings in ABBV

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$726,121,560	2,885,557	+164.4%	Shares	Defined	2026-08-14
2026-03-31	$237,343,571	1,091,285	-87.8%	Shares	Defined	2026-05-15
2025-12-31	$2,037,917,387	8,919,066	+37.3%	Shares	Defined	2026-02-17
2025-09-30	$1,503,737,686	6,494,505	+37.5%	Shares	Defined	2025-11-14
2025-06-30	$876,663,395	4,722,893	+169.3%	Shares	Defined	2025-08-14
2025-03-31	$367,433,335	1,753,691	+28.0%	Shares	Defined	2025-05-15
2024-12-31	$243,520,077	1,370,400	—	Shares	Defined	2025-02-14
No filing history on record for this holder in this stock.